Skip to main content
Fig. 2 | BMC Pregnancy and Childbirth

Fig. 2

From: Cost-effectiveness analysis of chromosomal microarray as a primary test for prenatal diagnosis in Hong Kong

Fig. 2

Laboratory workflow of the current algorithm for invasive prenatal diagnosis in the public healthcare system in Hong Kong. *QF-PCR is not commonly offered free of charge for patients with primary indication of DS screening positive / family history of chromosomal or genetic disorders. However, for patients who are willing to pay for self-financed aCGH, the laboratory will first perform QF-PCR for common aneuploidies detection. If QF-PCR results abnormal, aCGH will not be proceeded. ** Samples with inconclusive QFPCR results and subsequent normal karyotyping results will proceed to aCGH if patient is willing to pay for self-financed aCGH. aCGH: array comparative genomic hybridization; CNV: copy number variation; CVS: chorionic villous sampling; DS: Down syndrome; FISH: fluorescence in-situ hybridization; MLPA: multiplex-ligation dependent probe amplification; NT: nuchal translucency; QF-PCR: quantitative fluorescent polymerase chain reaction

Back to article page